UNSPSC 51322300: Antihyperlipidemic and hypocholesterolemic macromolecular substances

Antihyperlipidemic and hypocholesterolemic drugs compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size.

UNSPSC 51322300 Antihyperlipidemic and hypocholesterolemic macromolecular substances, a Class code, does not align with the recent state and local procurement activity tagged under it. The City of Tampa's April 2026 IFB for Advanced Life Support Medications (Solicitation 26P00188) solicits emergency-response pharmaceuticals including labetalol, epinephrine, adenosine, and diltiazem — acute-care vasopressors and cardiac agents used in emergency medical services, not lipid-management or cholesterol-reduction therapies that the code's nominal scope describes. The medications in the Tampa solicitation fall outside the antihyperlipidemic family and suggest either a misclassification in the procurement system or minimal recent activity aligned with the code's actual scope.

The single recent opportunity on record shows the City of Tampa Purchasing Department (via Tampa Fire Rescue in Hillsborough County, Florida) issuing an IFB with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The solicitation includes a Small Local Business Enterprise sheltered market designation with a 5 percent bid discount for SLBE participation not to exceed $10,000, and requires vendors to supply medications with a minimum nine-month shelf life, delivery within ten calendar days, and full warranty against defects for 365 days. The contract term is one year from award with two optional one-year renewal periods and up to three additional 30-day unilateral extensions. The code shows no other recent state or local activity and does not reflect active procurement of products within its nominal therapeutic category.